Fricke JG, Westerbergh F, McDougall L, Favaretto C, et al. Targeted beta(-)-Particle Plus Conversion and Auger-Electron Therapy with (161)Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study. J Nucl Med 2026;67:416-422.
PMID: 41381241